Stress Response Pathways in Cancer
Explore this paper's citation graph
Summary
This work focuses on the development and application of proteotoxic stress response pathways for induction of cell death in cancer cells, and the role of heat shock proteins in tumorigenesis.
- Type
- book
- Published
- 2015-01-01
- Cited by
- 9
- References
- 1,020
- Access
- Open access
- OpenAlex
- https://openalex.org/W1128618774
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:31814790
Keywords
Carcinogenesis, Fight-or-flight response, Stress (linguistics), Cancer, Neuroscience
References
- Peptide binding and release by proteins implicated as catalysts of protein assembly.
- Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and cIAP1 in Situ *
- 2-Deoxy-d-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo
- Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense
- Voltage-dependent anion channel (VDAC) as mitochondrial governator--thinking outside the box.
- Glycolysis inhibition for anticancer treatment
- The ATPase Cycle of the Endoplasmic Chaperone Grp94*
- The immunosuppressive and protective ability of glucose‐regulated protein 78 for improvement of alloimmunity in β cell transplantation
- Necroptosis: a specialized pathway of programmed necrosis.
- Bortezomib induces autophagic death in proliferating human endothelial cells.
- Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis
- In vivo imaging of CT26 mouse tumours by using cmHsp70.1 monoclonal antibody
- ATPases as drug targets: insights from heat shock proteins 70 and 90.
- Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
- Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
- Epstein-Barr virus induces invasion and metastasis factors.
- Improving cancer therapy by combining cell biological, physical, and molecular targeting strategies.
- Selectivity of the molecular chaperone-specific immunosuppressive agent 15-deoxyspergualin: modulation of Hsc70 ATPase activity without compromising DnaJ chaperone interactions.
- c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.
- c-Jun N-terminal kinase 抑制による大動脈瘤薬物治療
Cited by
- Development of two novel high-throughput assays to quantify ubiquitylated proteins in cell lysates: application to screening of new anti-malarials
- Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics.
- Modulation of therapy-induced senescence by reactive lipid aldehydes
- MKP-1 Negatively Regulates LPS-mediated IL-1β Production Through p38 Activation and HIF-1α Expression
- Caracterización de mecanismos de estrés asociados con apoptosis y señales inmunogénicas en células de melanoma murino tratadas con un extracto de plantas rico en polifenoles
- Stress et cancer : mythes et réalités
- Systemic deuteration of SCID mice using the water-isotopologue deuterium oxide (D2O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma
- Improvement of Docetaxel Efficacy through Simultaneous Blockade of Transcription Factors NF-κB and STAT-3 Using Pentoxifylline and Stattic in Prostate Cancer Cells
- Role of Chaperone Mediated Autophagy in Viral Infections
Related papers
- Tumorigenesis and cell evolution.
- Progress of the relationship between aberrant p53 protein and tumorigenesis
- Metastasis suppressors Nm23H1 and Nm23H2 differentially regulate neoplastic transformation and tumorigenesis.
- Psychogenic carcinogenesis: carcinogenesis is without exogenic carcinogens.
- miR-21 regulates N-methyl-N-nitro-N'-nitrosoguanidine-induced gastric tumorigenesis by targeting FASLG and BTG2.
- Inflammation and Carcinogenesis
- Inhibition of both skin and lung tumorigenesis by Car‐R mouse‐derived cancer modifier loci
- Predictive Genes in Adjacent Normal Tissue Are Preferentially Altered by sCNV during Tumorigenesis in Liver Cancer and May Rate Limiting
- Oncogenesis by mutations in anti-oncogenes: a view.